Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial (vol 374, pg 1503, 2009)

被引：0
|
作者：
Comi, G.
Martinelli, V
Rodegher, M.
机构：
来源：
LANCET | 2010年 / 375卷 / 9724期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1436 / 1436
页数：1
相关论文
共 50 条
  • [21] Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial
    Miller, David H.
    Weber, Thomas
    Grove, Richard
    Wardell, Claire
    Horrigan, Joseph
    Graff, Ole
    Atkinson, Gillian
    Dua, Pinky
    Yousry, Tarek
    MacManus, David
    Montalban, Xavier
    LANCET NEUROLOGY, 2012, 11 (02): : 131 - 139
  • [22] β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial (vol 393, pg 1597, 2019)
    Villanueva, C.
    Albillos, A.
    Genesca, J.
    LANCET, 2019, 393 (10190): : 2492 - 2492
  • [23] Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
    Confavreux, Christian
    O'Connor, Paul
    Comi, Giancarlo
    Freedman, Mark S.
    Miller, Aaron E.
    Olsson, Tomas P.
    Wolinsky, Jerry S.
    Bagulho, Teresa
    Delhay, Jean-Luc
    Dukovic, Deborah
    Truffinet, Philippe
    Kappos, Ludwig
    LANCET NEUROLOGY, 2014, 13 (03): : 247 - 256
  • [24] Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial (vol 8, pg 963, 2020)
    Khanna, Dinesh
    Lin, Celia J. F.
    Furst, Daniel E.
    Goldin, Jonathan
    Kim, Grace
    Kuwana, Masataka
    Allanore, Yannick
    Matucci-Cerinic, Marco
    Distler, Oliver
    Shima, Yoshihito
    van Laar, Jacob M.
    Spotswood, Helen
    Wagner, Bridget
    Siegel, Jeffrey
    Denton, Christopher P.
    LANCET RESPIRATORY MEDICINE, 2021, 9 (03): : E29 - E29
  • [25] Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial (vol 8, pg 963, 2020)
    Khanna, D.
    Lin, C. J. F.
    Furst, D. E.
    LANCET RESPIRATORY MEDICINE, 2020, 8 (10): : E75 - E75
  • [26] β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial
    Villanueva, Candid
    Albillos, Agustin
    Genesca, Joan
    Garcia-Pagan, Joan C.
    Calleja, Jose L.
    Aracil, Carles
    Banares, Rafael
    Morillas, Rosa M.
    Poca, Maria
    Penas, Beatriz
    Augustin, Salvador
    Abraldes, Juan G.
    Alvarado, Edilmar
    Torres, Ferran
    Bosch, Jaume
    Torras, X.
    Cadafalch, J.
    Ardevol, A.
    Graupera, I.
    Pavel, O.
    Diez, X.
    Vargas, H.
    Pernas, J. C.
    Barcons, M.
    Gallego, A.
    Soriano, G.
    Gordillo, J.
    Santalo, M.
    Benito, S.
    Guarner, C.
    Tellez, L.
    Martinez, J.
    Rodriguez-Gandia, M. A.
    Mesonero, F.
    Martin, C.
    Millan, L.
    Pons, M.
    Torrens, M.
    Berzigotti, A.
    Seijoo, S.
    Hernandez-Gea, V.
    Turon, F.
    Llach, J.
    Bru, C.
    Escorsell, A.
    Llop, E.
    Perello, C.
    Minana, J. M.
    Zaragoza, N.
    Buenestado, J.
    LANCET, 2019, 393 (10181): : 1597 - 1608
  • [27] Natalizumab improves disability on the Multiple Sclerosis Functional Composite in a randomised, double-blind, placebo-controlled study of patients with relapsing multiple sclerosis
    Munschauer, F.
    Giovannoni, G.
    O'Connor, P. W.
    Phillips, J. T.
    Polman, C. H.
    Pace, A.
    Hyde, R.
    Kim, R.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S124 - S125
  • [28] Efficacy of Two Dosing Frequencies of Subcutaneous Interferon Beta-1a on Risk of Conversion to Multiple Sclerosis in Patients with Clinically Isolated Syndrome: Results of a Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial (REFLEX)
    Comi, Giancarlo
    De Stefano, Nicola
    Freedman, Mark S.
    Kappos, Ludwig
    Hennessy, Brian
    Casset-Semanaz, Florence
    Rocak, Sanda
    Stubinski, Bettina
    NEUROLOGY, 2011, 76 (09) : A612 - A612
  • [29] A Randomized, Double-Blind, Placebo-Controlled Trial of Duloxetine for the Treatment of Pain in Patients with Multiple Sclerosis
    Vollmer, Timothy L.
    Robinson, Michael J.
    Risser, Richard C.
    Malcolm, Sandra K.
    PAIN PRACTICE, 2014, 14 (08) : 732 - 744
  • [30] Effect of Vitamin A Supplementation on Fatigue and Depression in Multiple Sclerosis Patients: A Double-blind Placebo-controlled Clinical Trial
    Bitarafan, Sama
    Saboor-Yaraghi, Aliakbar
    Sahraian, Mohammad-Ali
    Soltani, Danesh
    Nafissi, Shahriar
    Togha, Mansoureh
    Moghadam, Nahid Beladi
    Roostaei, Tina
    Honarvar, Niyaz Mohammadzadeh
    Harirchian, Mohammad-Hossein
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2016, 15 (01) : 13 - 19
12345